Philippines - English - FDA (Food And Drug Administration)

broadchem philippines biopharma corporation - live attenuated canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) , inactivated leptospira interrogans var. icterohaemorrhagiae , leptospira interrogans var. grippotyphosa , leptospira interrogans var. canicola , rabies virus (rv) vaccine (vet.) - freeze-dried powder for injection (im/sc) - formulation: each ml (dose) contains: canine distemper virus (cdv)...................>10^3 tcid50 canine adenovirus type 2 (cav-2)....................>10^3 tcid50 canine parvovirus (cpv)...............>10^4.5 tcid50 canine parainfluenza virus (cpiv).............>10^3 tcid50 leptospira interrogans var. icterohaemorrhagiae............................>10^7 titer leptospira interrogans var. grippotyphosa......... .. >10^7 titer leptospira interrogans var. canicola............>10^7 titer rabies virus........... > 2 iu tcid - tissue culture infectious dose iu - international unit

Philippines - English - FDA (Food And Drug Administration)

broadchem philippines biopharma corporation - live attenuated canine distemper virus (cdv) , canine adenovirus type 1 (cav-1) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) , inactivated leptospira interrogans var. icterohaemorrhagiae , leptospira interrogans var. grippotyphosa , leptospira interrogans var. sejroe , rabies virus (rv) vaccine (vet.) - freeze-dried powder for injection (sc) - formulation: each ml (dose) contains: live attenuated canine distemper virus (cdv)...... >10^2.7-4.5 eid50 canine adenovirus type 1 (cav-1). .................. >10^3.5-7.5 tcid 50 canine adenovirus type 2 (cav-2)................... >10^3.5-7.5 tcid50 canine parvovirus (cpv)............. >10^2.1-3.6 hau canine parainfluenza virus (cpiv)..................... >10^3-6 ccid 50 inactivated leptospira interrogans var. icterohaemorrhagiae....... >32 vnab50 leptospira interrogans var. grippotyphosa.......>32 vnab50 leptospira interrogans var. sejroe............... >32 vnab 50 rabies virus (rv)................ >2 iu eid - egg infectious dose tcid-tissue culture infectious dose ccid-cell culture infectious dose hau - haemagglutination unit iu - international unit

Philippines - English - FDA (Food And Drug Administration)

broadchem philippines biopharma corporation - live attenuated canine distemper virus (cdv) , canine adenovirus type 1 (cav-1) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) , inactivated leptospira interrogans var. icterohaemorrhagiae , leptospira interrogans var. grippotyphosa , leptospira interrogans var. sejroe vaccine (vet.) - freeze-dried powder for injection (sc) - formulation: each ml (dose) contains: canine distemper virus (cdv)..... ...........>10^2.7-4.5 eid50 canine adenovirus type 1 (cav-1)......................>10^3.5-7.5 tcid50 canine adenovirus type 2 (cav-2)..................... >10^3.5-7.5 tcid50 canine parvovirus (cpv).................................. >10^2.1-3,6 hau canine parainfluenza virus (cpiv)...................... >10^3-6 ccid50 leptospira interrogans var. icterohaemorrhagiae........ >1:32 titer leptospira interrogans var. grippotyphosa............... >1:32 titer leptospira interrogans var. sejroe...................>1:32 titer eid - egg infectious dose tcid-tissue culture infectious dose ccid-cell culture infectious dose hau - hemagglutination unit iu - international unit

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - canine adeno virus type 2; canine distemper virus; canine parainfluenza type 2; canine parvo virus - misc. vaccines or anti sera - canine adeno virus type 2 vaccine-viral active 0.0 p; canine distemper virus vaccine-viral active 0.0 p; canine parainfluenza type 2 vaccine-viral active 0.0 p; canine parvo virus vaccine-viral active 0.0 p - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 2 | canine distemper | canine parainfluenza | canine parvovirus | parvovirus

Philippines - English - FDA (Food And Drug Administration)

virbac philippines inc. - live attenuated canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , canine parainfluenza virus (cpiv) , inactivated leptospira interrogans var. canicola , l. interrogans var. icterohaemorrhagiae vaccine (vet.) - freeze-dried pellet for injection (sc) - formulation: each 1 ml (dose) contains: canine distemper virus (laderle strain) ............ 103-4.9 ccid50 canine adenovirus type 2 (manhattan strain) ..... 104-6 ccid 50 canine parvovirus (cpv 780916 strain) ............................. 105-6,8 ccid50 canine parainfluenza virus (manhattan strain) ................. 105-6.9 ccid 50 leptospira interrogans ser. canicola .................................... 4350-7330 u (antigenic mass) ser. icterohaemorrhagiae .............. 4250-6910 u (antigenic mass) ccid- cell culture infective dose u-elisa

Philippines - English - FDA (Food And Drug Administration)

philippines biopharma corporation - live attenuated canine distemper virus (cdv) , canine parainfluenza virus type 2 (cpiv) , canine adenovirus type 2 (cav-2) , canine parvovirus type 2b (cpv) vaccine (vet.) - freeze-dried pellet suspension for injection (sc) - each dose (1 ml) contains: canine parvovirus type 2b (cpv-2b bio) canine adenovirus type 2 virus (cav-2 bio strain) canine distemper virus (cdv bio 11/a strain) canine parainfluenza type 2 virus (cpiv-2 bio strain) tcid - tissue culture infectious dose 104.3 to 106.6 tcid50 103.6 to 105.3 tcid 50 103.1 to 105.1 tcid50 103.1 to 105.1 tcid50

Ireland - English - HPRA (Health Products Regulatory Authority)

virbac s.a. - canine distemper virus (lederle strain), canine adenovirus type 2 (manhattan strain), canine parvovirus (cpv 780916 strain), canine parainfluenza (manhattan strain), buffered isotonic solution, l.canicola, l.icterohaemorrhagiae - suspension for injection - unknown - live canine distemper virus vaccine + live canine adenovirus vaccine + live canine parainfluenza vi - canine - immunological - live vaccine

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - canine distemper virus - living; canine parainfluenza virus; canine adenovirus type 2 live (cav ii); canine parvo virus - misc. vaccines or anti sera - canine distemper virus - living vaccine-viral active 0.0 undefined; canine parainfluenza virus vaccine-viral active 0.0 undefined; canine adenovirus type 2 live (cav ii) vaccine-viral active 0.0 undefined; canine parvo virus vaccine-viral active 0.0 undefined - immunotherapy - dog | bitch | castrate | puppy - canine adenovirus - type 2 | canine distemper | canine parainfluenza | canine parvovirus | vaccine | equine rotavirus | parvovirus

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 8–9 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagie serovar icterohaemorrhagiae,to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa and to prevent mortality, clinical signs and infection caused by rabies virus.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - canine parainfluenza; leptospira icterohaemorrhagiae antigen; canine adeno virus type 2; canine coronavirus vaccine - antigen; canine distemper virus; canine parvo virus - misc. vaccines or anti sera - canine parainfluenza vaccine active 0.0 undefined; leptospira icterohaemorrhagiae antigen vaccine-antigen active 0.0 undefined; canine adeno virus type 2 vaccine-viral active 0.0 undefined; canine coronavirus vaccine - antigen vaccine-viral active 0.0 undefined; canine distemper virus vaccine-viral active 0.0 undefined; canine parvo virus vaccine-viral active 0.0 undefined - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 1 | canine adenovirus - type 2 | canine coronavirus | canine distemper | canine parainfluenza | canine parvovirus | leptospira icterohaemorrhagiae | parvovirus